LONDON, October 2021: LycaHealth has confirmed that it is investing more than £140 million to grow its business in the UK.
The figure, which will be spent over the next five years, will primarily be invested in the South East, where LycaHealth will add the largest independent hospital in Kent – KIMS Hospital – and its associated Medical Centre in Sevenoaks to its medical centres already operating in London. This is part of LycaHealth’s commitment to bringing high quality, accessible health services to local communities in the UK.
This investment will support KIMS hospital’s ambition to expand its services and accessibility to the local community in Kent and the adjoining areas. In collaboration with LycaHealth, the hospital will be able to combine the knowledge of its dedicated medical staff with the latest technologies to meet the growing demand for fast access to diagnostics and treatments.
Over the coming years, LycaHealth will be investing in upgrading KIMS hospital technology and facilities for existing and future enhanced services, including supporting the growth of cancer care, treatment and recovery facilities.
For LycaHealth – which already has state-of-the-art centres in Canary wharf and Orpington, including its recently opened breast and screening diagnostic centres – this investment is testament to the company’s commitment to increase its healthcare portfolio in the UK, and ensure patients have access to high quality medical care.
Prema Subaskaran, LycaHealth Chairperson, said “At LycaHealth, we strongly believe that if we’re to give people access to truly high quality and rapid medical care in the UK, then the private sector should work hand-in-hand with the NHS. Our investment in KIMS hospital is a step towards us achieving our long-term goal to provide a complete pathway from diagnosis through to treatment and aftercare for those patients that require it. Working with the KIMS team, we’ll be able to improve access to tech and strengthen the facilities on offer that ultimately improve each patient’s individual route to care, providing the best affordable healthcare for the local community”.
Commenting on the investment, Simon James said, “I’m delighted that LycaHealth is investing in KIMS Hospital and our Medical Centre in Sevenoaks. LycaHealth’s investment comes at a time when demand for healthcare, both NHS and private, continues to grow*. With the support and backing of LycaHealth, we have an excellent opportunity to build on our success to date. As the largest independent hospital in Kent, we play a critical role supporting the local community, both as a provider of outstanding healthcare and as a local employer, with over 400 employees. In partnership with LycaHealth, we have a fantastic opportunity to expand our healthcare provision across Kent, meeting the needs of local people.”
Don't miss out on any breaking news or insightful opinions!
Subscribe to our free newsletter and stay updated on the go!
By submitting this form, you are consenting to receive marketing emails from: Global Banking & Finance Review. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email.
Macfarlanes LLP acted as legal advisors to LycaHealth.
LycaHealth was founded in 2015 by Prema Subaskaran, who as Chairperson oversees the operational and strategic development of the business, including expansion into new markets. LycaHealth offers comprehensive, multi-speciality consultations, state of the art leading diagnostic imaging facilities, JAG accredited endoscopy facilities, on-site treatment and wellness services for local residents, professionals and internationals.
LycaHealth is part of Lyca Group, founded by Allirajah Subaskaran, a British multinational corporation delivering low-cost, high-quality products and services to communities across the globe. Lyca Group’s portfolio is diverse, with an offering across Telecommunications, Entertainment, Travel and Tourism, Healthcare, Media, Technology, Financial Services, Marketing and Hospitality.
